Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets - (Unaudited)

v3.24.1.u1
Consolidated Balance Sheets - (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 121,492 $ 119,555
Cash held in escrow 18,460 49,091
Real estate inventories 1,196,506 1,121,726
Goodwill 68,639 68,639
Other assets 133,818 107,873
Total assets 1,543,377 1,471,232
Liabilities    
Accounts payable 88,707 77,969
Accrued expenses and other liabilities 192,115 160,256
Line of credit facility, net  348,237 307,631
Senior notes, net 236,913 236,143
Total liabilities 866,853 782,880
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Preferred stock, $0.0001 par value, 50,000,000 shares authorized, none issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 0 0
Common stock, $0.0001 par value, 500,000,000 shares authorized, 41,525,731 issued and 36,129,736 outstanding as of March 31, 2024, 41,382,453 issued and 36,520,894 outstanding as of December 31, 2023 4 4
Additional paid-in capital 459,521 465,290
Retained earnings 187,774 187,584
Total stockholders’ equity 647,299 652,878
Noncontrolling interests 29,225 35,474
Total equity 676,524 688,352
Total liabilities and equity 1,543,377 1,471,232
Related Party    
Assets    
Due from affiliates 4,462 4,348
Liabilities    
Due to affiliates $ 881 $ 881